Literature DB >> 8838495

Expression pattern of type II collagen mRNA during early vertebral development in the human embryo.

S Krengel1, W Götz, R Herken.   

Abstract

The role of extracellular matrix molecules in ontogenetic differentiation processes is a matter of increasing interest. In cartilage development, type II collagen is suspected of promoting chondrogenic differentiation, since its expression has been demonstrated in a range of precartilaginous tissues of vertebrate species. Up to now, no studies supplying a coherent description of type II collagen expression in the skeletogenesis of human embryos including early embryonic stages have been published. In this work, we examine the temporal and spatial distribution of type II collagen mRNA during vertebral column development in human embryos from 4 to 12 weeks of gestation using non-radioactive in situ hybridization. The onset of gene expression was demonstrable in the 5th week in precartilaginous mesenchymal cells and in notochordal cells. Additionally, we found a weaker hybridization signal in the mesenchymal precursors of the intervertebral discs. In the anlagen of the axial skeleton, type II collagen expression decreased during osteogenic reconstruction in the 11th/12th week, whereas expression continued in the notochordal remnants of the future nuclei pulposi. The results suggest a relatively late occurrence of type II collagen in human vertebral development compared with other vertebrate species. The distribution of gene expression is concordant with a possible role of this molecule in promoting differentiation of mesenchymal cells into chondrocytes. The mechanism of this influence remains to be established.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838495     DOI: 10.1007/bf00186832

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  28 in total

1.  The role of the neural tube and notochord in development of the axial skeleton of the chick.

Authors:  R L WATTERSON; I FOWLER; B J FOWLER
Journal:  Am J Anat       Date:  1954-11

2.  The timing and sequence of events in the development of the human vertebral column during the embryonic period proper.

Authors:  R O'Rahilly; D B Meyer
Journal:  Anat Embryol (Berl)       Date:  1979-10

3.  Expression of collagens I, II, X, and XI and aggrecan mRNAs by bovine growth plate chondrocytes in situ.

Authors:  L J Sandell; J V Sugai; S B Trippel
Journal:  J Orthop Res       Date:  1994-01       Impact factor: 3.494

Review 4.  The aminopropeptide of collagen.

Authors:  R Timpl; R W Glanville
Journal:  Clin Orthop Relat Res       Date:  1981 Jul-Aug       Impact factor: 4.176

5.  Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage.

Authors:  T Aigner; H Stöss; G Weseloh; G Zeiler; K von der Mark
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1992

6.  Altered Pax gene expression in murine notochord mutants: the notochord is required to initiate and maintain ventral identity in the somite.

Authors:  S Dietrich; F R Schubert; P Gruss
Journal:  Mech Dev       Date:  1993-12       Impact factor: 1.882

7.  Immunofluorescent staining for collagen and proteoglycan in normal and scoliotic intervertebral discs.

Authors:  H K Beard; S Roberts; J P O'Brien
Journal:  J Bone Joint Surg Br       Date:  1981

8.  Widespread distribution of type II collagen during embryonic chick development.

Authors:  R A Kosher; M Solursh
Journal:  Dev Biol       Date:  1989-02       Impact factor: 3.582

9.  Human PAX gene expression and development of the vertebral column.

Authors:  C A Smith; R S Tuan
Journal:  Clin Orthop Relat Res       Date:  1994-05       Impact factor: 4.176

10.  Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development.

Authors:  K S Cheah; E T Lau; P K Au; P P Tam
Journal:  Development       Date:  1991-04       Impact factor: 6.868

View more
  1 in total

1.  Segmentation in staged human embryos: the occipitocervical region revisited.

Authors:  Fabiola Müller; Ronan O'Rahilly
Journal:  J Anat       Date:  2003-09       Impact factor: 2.610

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.